Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients
Jun Li(Sun Yat-sen University), Yongjun Guo(Tianjin Agricultural University), Qingxin Xia(Zhengzhou University), Yi Wang(Zhengzhou University), Hongle Li(Shanghai Jiao Tong University), Ping Wang(Peking University), Yanlin Luo(Zhengzhou University), Jie Ma(Renal Research Institute), Bing Wei(Guangdong Medical College), Xiaoyan Wang(University of California, Los Angeles), Cuiyun Zhang(Zhengzhou University), Li Wang(China Three Gorges University), Sile Han(Zhengzhou University)
Cited by 11
Related Papers
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
SETD2: an epigenetic modifier with tumor suppressor functionality
|Oncotarget|2016|167